OpenVSafe by OpenVAERS
Search V-safe

AYR-20931-19151

3 vaccinations 6 coded responses 10 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
956 / CA
Registered
2021-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-23
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-22
    Registered in v-safe
  4. 2021-12-23
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Site: Swelling · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Cognitive
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-12-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  7. 2021-12-30
    Health check-in — day 7, dose 3
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2022-01-06
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  9. 2022-01-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  10. 2022-01-20
    Survey response — day 28, dose 3
    MedDRA: Diarrhoea, Nausea, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Vertigo Diarrhea Nausea
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-27
    Survey response — day 35, dose 3
    MedDRA: Pruritus, Rash — Feeling: Good
    Free text: Itchy skin, some look like a bug bite, but in unlikely place like midriff, end of day when Ive been wearing 3 layers of clothing, or suddenly late evening on my face when I had not been outside. gone by morning, altho bug bites usually last on me.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-05
    Survey response — day 42, dose 3
    MedDRA: Oropharyngeal pain, Oxygen saturation decreased, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Temp 100.4, sore throat, chest and lung congestion, spo2 92-96, once 84%
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-03-24
    Survey response — 3 months, dose 3
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Worsened long haul cognitive symptoms
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-03-24
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  15. 2022-03-28
  16. 2022-06-23
    Survey response — 6 months, dose 3
    MedDRA: Fatigue — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Increasingly tired
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-02Pfizer-BioNTech No
22021-03-23Pfizer-BioNTech No
32021-12-23Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-27

Systemic reaction (other): Cognitive

Release 10 — day 28, dose 3

2022-01-20

Symptoms: Vertigo Diarrhea Nausea

Release 11 — day 35, dose 3

2022-01-27

Symptoms: Itchy skin, some look like a bug bite, but in unlikely place like midriff, end of day when Ive been wearing 3 layers of clothing, or suddenly late evening on my face when I had not been outside. gone by morning, altho bug bites usually last on me.

Release 11 — day 42, dose 3

2022-02-05

Symptoms: Temp 100.4, sore throat, chest and lung congestion, spo2 92-96, once 84%

Release 11 — 3 months, dose 3

2022-03-24

Symptoms: Worsened long haul cognitive symptoms

Release 12 — 6 months, dose 3

2022-06-23

Symptoms: Increasingly tired

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated · · ✓
SDDiarrhoea · · ✓
SDFatigue · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDOxygen saturation decreased · · ✓
SDPre-existing disease · · ✓
SDPruritus · · ✓
SDPyrexia · · ✓
SDRash · · ✓
SDRespiratory tract congestion · · ✓
SDVertigo · · ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release